Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,431
archived clinical trials in
Anemia

ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox
A 5 Year Observational Study (Registry) of Children Aged 2 to <6 Years at Enrollment With Transfusional Hemosiderosis Treated With Deferasirox
Status: Enrolling
Updated:  12/26/2015
Children's Medical Center
mi
from
Dayton, OH
ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox
A 5 Year Observational Study (Registry) of Children Aged 2 to <6 Years at Enrollment With Transfusional Hemosiderosis Treated With Deferasirox
Status: Enrolling
Updated: 12/26/2015
Children's Medical Center
mi
from
Dayton, OH
Click here to add this to my saved trials
ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox
A 5 Year Observational Study (Registry) of Children Aged 2 to <6 Years at Enrollment With Transfusional Hemosiderosis Treated With Deferasirox
Status: Enrolling
Updated:  12/26/2015
Oklahoma State University Health Sciences Center
mi
from
Oklahoma City, OK
ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox
A 5 Year Observational Study (Registry) of Children Aged 2 to <6 Years at Enrollment With Transfusional Hemosiderosis Treated With Deferasirox
Status: Enrolling
Updated: 12/26/2015
Oklahoma State University Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox
A 5 Year Observational Study (Registry) of Children Aged 2 to <6 Years at Enrollment With Transfusional Hemosiderosis Treated With Deferasirox
Status: Enrolling
Updated:  12/26/2015
Penn State University / Milton S. Hershey Medical Center
mi
from
Hershey, PA
ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox
A 5 Year Observational Study (Registry) of Children Aged 2 to <6 Years at Enrollment With Transfusional Hemosiderosis Treated With Deferasirox
Status: Enrolling
Updated: 12/26/2015
Penn State University / Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox
A 5 Year Observational Study (Registry) of Children Aged 2 to <6 Years at Enrollment With Transfusional Hemosiderosis Treated With Deferasirox
Status: Enrolling
Updated:  12/26/2015
St. Jude Childrens Research Hosp, Memphis
mi
from
Memphis, TN
ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox
A 5 Year Observational Study (Registry) of Children Aged 2 to <6 Years at Enrollment With Transfusional Hemosiderosis Treated With Deferasirox
Status: Enrolling
Updated: 12/26/2015
St. Jude Childrens Research Hosp, Memphis
mi
from
Memphis, TN
Click here to add this to my saved trials
ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox
A 5 Year Observational Study (Registry) of Children Aged 2 to <6 Years at Enrollment With Transfusional Hemosiderosis Treated With Deferasirox
Status: Enrolling
Updated:  12/26/2015
Cook's Children's Medical Center
mi
from
Fort Worth, TX
ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox
A 5 Year Observational Study (Registry) of Children Aged 2 to <6 Years at Enrollment With Transfusional Hemosiderosis Treated With Deferasirox
Status: Enrolling
Updated: 12/26/2015
Cook's Children's Medical Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox
A 5 Year Observational Study (Registry) of Children Aged 2 to <6 Years at Enrollment With Transfusional Hemosiderosis Treated With Deferasirox
Status: Enrolling
Updated:  12/26/2015
Texas Children's Hospital
mi
from
Houston, TX
ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox
A 5 Year Observational Study (Registry) of Children Aged 2 to <6 Years at Enrollment With Transfusional Hemosiderosis Treated With Deferasirox
Status: Enrolling
Updated: 12/26/2015
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox
A 5 Year Observational Study (Registry) of Children Aged 2 to <6 Years at Enrollment With Transfusional Hemosiderosis Treated With Deferasirox
Status: Enrolling
Updated:  12/26/2015
Children's Hospital of The King's Daughters
mi
from
Norfolk, VA
ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox
A 5 Year Observational Study (Registry) of Children Aged 2 to <6 Years at Enrollment With Transfusional Hemosiderosis Treated With Deferasirox
Status: Enrolling
Updated: 12/26/2015
Children's Hospital of The King's Daughters
mi
from
Norfolk, VA
Click here to add this to my saved trials
In Vivo Raman Spectroscopy of Human Capillary Beds
In Vivo Raman Spectroscopy (IVRS) of Human Fingertip Capillary Beds
Status: Enrolling
Updated:  12/30/2015
University Dialsyis Center
mi
from
Syracuse, NY
In Vivo Raman Spectroscopy of Human Capillary Beds
In Vivo Raman Spectroscopy (IVRS) of Human Fingertip Capillary Beds
Status: Enrolling
Updated: 12/30/2015
University Dialsyis Center
mi
from
Syracuse, NY
Click here to add this to my saved trials
Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia
A Randomized, Open-Label, Wait-list Control Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia and a Serum Ferritin Between 20 and 200 ng/mL
Status: Enrolling
Updated:  1/7/2016
University of Chicago Medical Center
mi
from
Chicago, IL
Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia
A Randomized, Open-Label, Wait-list Control Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia and a Serum Ferritin Between 20 and 200 ng/mL
Status: Enrolling
Updated: 1/7/2016
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia
A Randomized, Open-Label, Wait-list Control Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia and a Serum Ferritin Between 20 and 200 ng/mL
Status: Enrolling
Updated:  1/7/2016
Johns Hopkins University Geriatrics Center
mi
from
Baltimore, MD
Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia
A Randomized, Open-Label, Wait-list Control Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia and a Serum Ferritin Between 20 and 200 ng/mL
Status: Enrolling
Updated: 1/7/2016
Johns Hopkins University Geriatrics Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia
A Randomized, Open-Label, Wait-list Control Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia and a Serum Ferritin Between 20 and 200 ng/mL
Status: Enrolling
Updated:  1/7/2016
Case Western Reserve University Medical Center
mi
from
Cleveland, OH
Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia
A Randomized, Open-Label, Wait-list Control Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia and a Serum Ferritin Between 20 and 200 ng/mL
Status: Enrolling
Updated: 1/7/2016
Case Western Reserve University Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia
A Randomized, Open-Label, Wait-list Control Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia and a Serum Ferritin Between 20 and 200 ng/mL
Status: Enrolling
Updated:  1/7/2016
Institute For Advanced Studies in Aging
mi
from
Falls Church, VA
Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia
A Randomized, Open-Label, Wait-list Control Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia and a Serum Ferritin Between 20 and 200 ng/mL
Status: Enrolling
Updated: 1/7/2016
Institute For Advanced Studies in Aging
mi
from
Falls Church, VA
Click here to add this to my saved trials
Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia
A Randomized, Open-Label, Wait-list Control Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia and a Serum Ferritin Between 20 and 200 ng/mL
Status: Enrolling
Updated:  1/7/2016
University of Illinois at Chicago
mi
from
Chicago, IL
Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia
A Randomized, Open-Label, Wait-list Control Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia and a Serum Ferritin Between 20 and 200 ng/mL
Status: Enrolling
Updated: 1/7/2016
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial
Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial
Status: Enrolling
Updated:  1/7/2016
Washington University School of Medicine
mi
from
St. Louis, MO
Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial
Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial
Status: Enrolling
Updated: 1/7/2016
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)
Sparing Conversion to Abnormal TCD Elevation (SCATE) - a Phase III Clinical Trial to Compare Standard Care (Observation) With Alternative Therapy (Hydroxyurea) for Reducing the Risk of Converting to an Abnormal TCD Velocity in Children With Sickle Cell Anemia and Conditional Pre-treatment TCD Velocities.
Status: Enrolling
Updated:  1/13/2016
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)
Sparing Conversion to Abnormal TCD Elevation (SCATE) - a Phase III Clinical Trial to Compare Standard Care (Observation) With Alternative Therapy (Hydroxyurea) for Reducing the Risk of Converting to an Abnormal TCD Velocity in Children With Sickle Cell Anemia and Conditional Pre-treatment TCD Velocities.
Status: Enrolling
Updated: 1/13/2016
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)
Sparing Conversion to Abnormal TCD Elevation (SCATE) - a Phase III Clinical Trial to Compare Standard Care (Observation) With Alternative Therapy (Hydroxyurea) for Reducing the Risk of Converting to an Abnormal TCD Velocity in Children With Sickle Cell Anemia and Conditional Pre-treatment TCD Velocities.
Status: Enrolling
Updated:  1/13/2016
Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti (HEMORIO)
mi
from
Centro,
Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)
Sparing Conversion to Abnormal TCD Elevation (SCATE) - a Phase III Clinical Trial to Compare Standard Care (Observation) With Alternative Therapy (Hydroxyurea) for Reducing the Risk of Converting to an Abnormal TCD Velocity in Children With Sickle Cell Anemia and Conditional Pre-treatment TCD Velocities.
Status: Enrolling
Updated: 1/13/2016
Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti (HEMORIO)
mi
from
Centro,
Click here to add this to my saved trials
Probiotics in the Treatment of Iron Deficiency in Children With Restless Leg Syndrome
Probiotics in the Treatment of Iron Deficiency in Children With Restless Leg Syndrome-A Double-blind, Randomized Controlled Study
Status: Enrolling
Updated:  1/19/2016
Childrens Hospitals And Clinics Of Minnesota
mi
from
St. Paul, MN
Probiotics in the Treatment of Iron Deficiency in Children With Restless Leg Syndrome
Probiotics in the Treatment of Iron Deficiency in Children With Restless Leg Syndrome-A Double-blind, Randomized Controlled Study
Status: Enrolling
Updated: 1/19/2016
Childrens Hospitals And Clinics Of Minnesota
mi
from
St. Paul, MN
Click here to add this to my saved trials
Universal Screening for Tuberculosis and Anemia With the CHICA System
Universal Screening for Tuberculosis and Anemia With the CHICA System
Status: Enrolling
Updated:  1/22/2016
Children's Health Services Research
mi
from
Indianapolis, IN
Universal Screening for Tuberculosis and Anemia With the CHICA System
Universal Screening for Tuberculosis and Anemia With the CHICA System
Status: Enrolling
Updated: 1/22/2016
Children's Health Services Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Non-Invasive Hemoglobin Study
Non-Invasive Hemoglobin Multi-Center Observational Study
Status: Enrolling
Updated:  1/26/2016
BloodSource
mi
from
Sacramento, CA
Non-Invasive Hemoglobin Study
Non-Invasive Hemoglobin Multi-Center Observational Study
Status: Enrolling
Updated: 1/26/2016
BloodSource
mi
from
Sacramento, CA
Click here to add this to my saved trials
Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer
Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent GVHD After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer
Status: Enrolling
Updated:  1/28/2016
Indiana University Cancer Center
mi
from
Indianapolis, IN
Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer
Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent GVHD After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer
Status: Enrolling
Updated: 1/28/2016
Indiana University Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Birmingham, AL
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Mobile, AL
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Montgomery, AL
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Montgomery, AL
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Encino, CA
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Encino, CA
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Irvine, CA
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Irvine, CA
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Los Angeles, CA
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Monterey Park, CA
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Monterey Park, CA
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Riverside, CA
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Riverside, CA
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Sacramento, CA
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
San Diego, CA
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
San Francisco, CA
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
San Jose, CA
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
San Jose, CA
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Colorado Springs, CO
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Denver, CO
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Lakewood, CO
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Lakewood, CO
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Ocala, FL
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Ocala, FL
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Pembroke Pines, FL
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Atlanta, GA
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Augusta, GA
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Augusta, GA
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Chicago, IL
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Maywood, IL
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Maywood, IL
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Louisville, KY
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Covington, LA
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Covington, LA
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Boston, MA
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Springfield, MA
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Springfield, MA
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Detroit, MI
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Brooklyn Center, MN
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Brooklyn Center, MN
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Paterson, NJ
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Paterson, NJ
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Albuquerque, NM
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated:  1/29/2016
Clinical Research Facility
mi
from
Bronx, NY
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.
Status: Enrolling
Updated: 1/29/2016
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials